Invesco Biotechnology & Genome ETF
PBE
PBE
102 hedge funds and large institutions have $78.5M invested in Invesco Biotechnology & Genome ETF in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
25% less capital invested
Capital invested by funds: $105M → $78.5M (-$26.6M)
Holders
102
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.33M | |
| 2 | +$924K | |
| 3 | +$906K | |
| 4 |
CW
CreativeOne Wealth
Overland Park,
Kansas
|
+$813K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$654K |
Top Sellers
| 1 | -$16M | |
| 2 | -$11.7M | |
| 3 | -$2.34M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$1.52M |
| 5 |
M&T Bank
Buffalo,
New York
|
-$576K |